MedHub was founded in early 2018 by Or Bruch El, with the aim of helping cardiologists deliver better care while simplifying their workflow.
Our technology ensures optimal clinical outcomes by significantly reducing post-procedure adverse events and mortality rate along with preventing unnecessary therapeutic procedures, as well as additional diagnostic invasive interventions.
Why are we doing it?
We believe that adopting new technologies such as AI and machine learning can enhance the medical field by leading to a more efficient, accurate and better overall care for every patient.
But it doesn’t end there…
Our Second Why: We believe that great care needs to be affordable and accessible for every patient whether he/she has health insurance or not.
AutocathFFR™
AutocathFFR™, an automated decision support system for interventional cardiologists use.
The AutocathFFR™ Analysis is the only end-to-end non-invasive diagnostic tool that aids clinicians in quantifying arterial stenosis to determine whether significant narrowing is present. AutocathFFR™ facilitates the selection of the most appropriate, effective, and evidence-based revascularization strategy
- Rapid, seamless, non-invasive image-based FFR
- Automated stenosis identification and classification
- Real-time stenosis tracking system
- AutocathFFR™ can operate in offline mode
Our Partners.
Regulatory Status
CE aprroval
AMAR aprroval
Founder & CEO
Or Bruch El
Chief Executive Officer
Or Baruch El is a Co-founder and CEO of MedHub.
He is responsible for the overall strategy, direction, and vision for MedHub. Or ran over the past 5 years several companies in a variety sectors such as real-time VR video platform for training of physicians and healthcare-providers (VRMS) and a platform for distribution of video contents (Scallopress).
As MedHub’s CEO since 2018 Or has developed close relationships with clinical and business leaders in the Cardiology field and leads partnerships and investor relations. He is also an active contributor to MedHub’s science and engineering teams, with a particular focus on automatic medical image analysis.
Or set a goal to sacrifice each moment and effort of his life in order to transform the way we access and receive healthcare. Or is committed to putting all his energy to ensure optimum benefits to Medhub customers and shareholders.
COO and Regulatory Affairs
Yarden Bruch El
COO and Regulatory Affairs
Yarden David is the COO and Regulatory Affairs Manager of Medhub. Yarden brings more than 5 years of experience in the medical device field as a Quality, Regulatory and Clinical Affairs Manager. Yarden has vast experience with medical software development and cybersecurity requirements and hands-on experience and knowledge in the complete medical devices regulatory cycle by obtaining worldwide regulatory approvals such as CE, FDA, TGA and AMAR clearances.
Yarden has completed with distinction her B.Sc degree in Biomedical Engineering at the Ben Gurion University of the Negev. She has served as a head of a technological intelligence research team at the research division of the IDF Intelligence Force, following graduation of prestige course at 8200 unit.
The Team.
VP R&D
Data Annotator
Algorithm Developer
Data Annotator
Chairman of board
Prof. Rafael Beyar
Rafael Beyar, MD, DSc, MPH, and Professor of Medicine and Biomedical Engineering, is the former director of Rambam Health Care Campus. Beyar received his MD from Tel Aviv University (1977), a DSc from the Technion (1983), and his MPH from the Bloomberg School of Public Health (2008). He trained at Johns Hopkins Cardiology and has held a visiting Professor appointment there. Beyar served as Dean of the Technion’s Ruth & Bruce Rappaport Faculty of Medicine (1999–2005); under his leadership, Professors Avram Hershko and Aaron Ciechanover were awarded the Nobel Prize in Chemistry in 2004. An interventional cardiologist with research focusing on cardiovascular engineering, development of stents, and the first robotic coronary catheterization system, Beyar has authored numerous publications, several patents, 15 books, and is a recipient of several awards.
ADVISORY BOARD
Prof. Amir Lerman
Amir Lerman, MD is a professor of medicine and a consultant in the Department of Cardiovascular Diseases at the Mayo Graduate School of Medicine. Dr. Lerman serves as an associate chair and the director for research for the Department of Cardiovascular Diseases and the director of the Mayo Clinic Cardiovascular Research Center. In addition, Dr. Lerman leads the Mayo-Israeli start-up companies initiative and serves as a faculty member of the Merage Institute.
Prof. Ariel Roguin
Director Hillel Yaffe Medical Center’s Cardiology Division, held a research and interventional cardiology fellowship at Johns Hopkins Medical Center in Baltimore, USA. Prof. Roguin also holds a PhD in medicine (angiogenesis) and he is an expert in the treatment of stenosis and obstruction of the coronary arteries. He focusses particularly on high-risk patients and during a heart attack. He has published over 200 academic articles. In the recent years, he served as Director of the Invasive Cardiology Unit at Rambam Medical Center in Haifa.
Dr. Yair Feld
Dr. Feld completed his internship and residency in internal medicine at Rambam Health Care Campus as well as a Cardiology fellowship at the same institution. During this period he founded Paragate Medical that develops a dedicated device for fluids removal in patients with heart failure and diuretic resistance. He then spent a two-year fellowship in Interventional cardiology at the University of Toronto. Currently, he holds the position of senior interventional cardiologist and head of Rambam innovation lab.
Mr. Ehud Barak
Ehud Barak has served on MedHub’s strategic board as business development advisor since August 2021. Mr. Barak served as the 10th Prime Minister of Israel and the 14th Chief of Staff, after previously heading the Military Intelligence Directorate. He also served as Minister of Defense, Minister of Foreign Affairs, and Minister of the Interior for various government administrations in the private sector Mr. Barak has consulted and acted as a strategic advisor for a number of prestigious private equity firms and hedge funds. Mr. Barak also currently serves on the board of three other Israeli companies: Carbyne Ltd., Guardicore Ltd., and Cypertoka Ltd. Mr. Barak holds a B.S. degree in mathematics and physics from the Hebrew University in Jerusalem and received his M.S.C in economic engineering systems from Stanford University. Since September 2016, he has served as Senior Fellow non-resident at the Belfer Center for Science and International Affairs at Harvard University.
Attached is the selected image of Ehud.
Mr. Natanel Davidovits
Natanel is a seasoned algorithm & AI researcher, with over 10 years of industry experience. His expertise includes bottom-up R&D of innovative large-scale projects of classical and deep-learning computer-vision, natural-language-understanding, recommendation-systems, data-science, multi-physical systems modeling, and optimization. Before joining MedHub, Natanel had led early-stage startup teams through initial research up to innovative enterprise solutions, for tomorrow’s advances in AI.
Getting in touch with us is easy!